Annual CFO
-$39.97 M
-$22.65 M-130.85%
31 December 2023
Summary:
Annovis Bio annual cash flow from operations is currently -$39.97 million, with the most recent change of -$22.65 million (-130.85%) on 31 December 2023. During the last 3 years, it has fallen by -$36.00 million (-906.53%). ANVS annual CFO is now -8287.68% below its all-time high of -$476.50 thousand, reached on 31 December 2019.ANVS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$3.20 M
+$173.90 K+5.15%
30 September 2024
Summary:
Annovis Bio quarterly cash flow from operations is currently -$3.20 million, with the most recent change of +$173.90 thousand (+5.15%) on 30 September 2024. Over the past year, it has increased by +$6.17 million (+65.83%). ANVS quarterly CFO is now -7061.74% below its all-time high of -$44.70 thousand, reached on 30 September 2019.ANVS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$22.97 M
+$6.17 M+21.17%
30 September 2024
Summary:
Annovis Bio TTM cash flow from operations is currently -$22.97 million, with the most recent change of +$6.17 million (+21.17%) on 30 September 2024. Over the past year, it has increased by +$11.24 million (+32.85%). ANVS TTM CFO is now -14542.64% below its all-time high of -$156.90 thousand, reached on 31 March 2018.ANVS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANVS Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -130.8% | +65.8% | +32.9% |
| 3 y3 years | -906.5% | -83.6% | -182.6% |
| 5 y5 years | -7054.9% | -7061.7% | -4493.0% |
ANVS Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -906.5% | at low | -83.6% | +72.5% | -182.6% | +42.5% |
| 5 y | 5 years | -8287.7% | at low | -7061.7% | +72.5% | -4721.5% | +42.5% |
| alltime | all time | -8287.7% | at low | -7061.7% | +72.5% | <-9999.0% | +42.5% |
Annovis Bio Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.20 M(-5.2%) | -$22.97 M(-21.2%) |
| June 2024 | - | -$3.38 M(-52.0%) | -$29.14 M(-17.6%) |
| Mar 2024 | - | -$7.03 M(-24.9%) | -$35.37 M(-11.5%) |
| Dec 2023 | -$39.97 M(+130.9%) | -$9.37 M(-0.1%) | -$39.97 M(+16.8%) |
| Sept 2023 | - | -$9.37 M(-2.5%) | -$34.21 M(+18.7%) |
| June 2023 | - | -$9.61 M(-17.4%) | -$28.83 M(+11.2%) |
| Mar 2023 | - | -$11.63 M(+222.1%) | -$25.92 M(+49.7%) |
| Dec 2022 | -$17.31 M(+89.6%) | -$3.61 M(-9.5%) | -$17.31 M(+11.9%) |
| Sept 2022 | - | -$3.99 M(-40.4%) | -$15.47 M(+17.0%) |
| June 2022 | - | -$6.69 M(+121.5%) | -$13.23 M(+36.7%) |
| Mar 2022 | - | -$3.02 M(+70.8%) | -$9.68 M(+6.0%) |
| Dec 2021 | -$9.13 M | -$1.77 M(+1.5%) | -$9.13 M(+12.3%) |
| Sept 2021 | - | -$1.74 M(-44.6%) | -$8.13 M(+11.2%) |
| June 2021 | - | -$3.14 M(+27.1%) | -$7.31 M(+33.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$2.47 M(+223.1%) | -$5.48 M(+37.9%) |
| Dec 2020 | -$3.97 M(+733.3%) | -$765.90 K(-17.0%) | -$3.97 M(+21.9%) |
| Sept 2020 | - | -$922.70 K(-29.7%) | -$3.26 M(+36.9%) |
| June 2020 | - | -$1.31 M(+35.2%) | -$2.38 M(+95.3%) |
| Mar 2020 | - | -$970.40 K(+1748.4%) | -$1.22 M(+155.7%) |
| Dec 2019 | -$476.50 K(-14.7%) | -$52.50 K(+17.4%) | -$476.50 K(-4.7%) |
| Sept 2019 | - | -$44.70 K(-70.3%) | -$500.20 K(-14.4%) |
| June 2019 | - | -$150.60 K(-34.1%) | -$584.30 K(-7.3%) |
| Mar 2019 | - | -$228.70 K(+200.1%) | -$630.40 K(+12.9%) |
| Dec 2018 | -$558.60 K(+3.9%) | -$76.20 K(-40.8%) | -$558.60 K(+15.8%) |
| Sept 2018 | - | -$128.80 K(-34.5%) | -$482.40 K(+36.4%) |
| June 2018 | - | -$196.70 K(+25.4%) | -$353.60 K(+125.4%) |
| Mar 2018 | - | -$156.90 K | -$156.90 K |
| Dec 2017 | -$537.50 K | - | - |
FAQ
- What is Annovis Bio annual cash flow from operations?
- What is the all time high annual CFO for Annovis Bio?
- What is Annovis Bio annual CFO year-on-year change?
- What is Annovis Bio quarterly cash flow from operations?
- What is the all time high quarterly CFO for Annovis Bio?
- What is Annovis Bio quarterly CFO year-on-year change?
- What is Annovis Bio TTM cash flow from operations?
- What is the all time high TTM CFO for Annovis Bio?
- What is Annovis Bio TTM CFO year-on-year change?
What is Annovis Bio annual cash flow from operations?
The current annual CFO of ANVS is -$39.97 M
What is the all time high annual CFO for Annovis Bio?
Annovis Bio all-time high annual cash flow from operations is -$476.50 K
What is Annovis Bio annual CFO year-on-year change?
Over the past year, ANVS annual cash flow from operations has changed by -$22.65 M (-130.85%)
What is Annovis Bio quarterly cash flow from operations?
The current quarterly CFO of ANVS is -$3.20 M
What is the all time high quarterly CFO for Annovis Bio?
Annovis Bio all-time high quarterly cash flow from operations is -$44.70 K
What is Annovis Bio quarterly CFO year-on-year change?
Over the past year, ANVS quarterly cash flow from operations has changed by +$6.17 M (+65.83%)
What is Annovis Bio TTM cash flow from operations?
The current TTM CFO of ANVS is -$22.97 M
What is the all time high TTM CFO for Annovis Bio?
Annovis Bio all-time high TTM cash flow from operations is -$156.90 K
What is Annovis Bio TTM CFO year-on-year change?
Over the past year, ANVS TTM cash flow from operations has changed by +$11.24 M (+32.85%)